0001209191-21-007884.txt : 20210204
0001209191-21-007884.hdr.sgml : 20210204
20210204184753
ACCESSION NUMBER: 0001209191-21-007884
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210202
FILED AS OF DATE: 20210204
DATE AS OF CHANGE: 20210204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TEVANIAN AVADIS
CENTRAL INDEX KEY: 0001214091
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32431
FILM NUMBER: 21592690
MAIL ADDRESS:
STREET 1: DOLBY LABORATORIES INC
STREET 2: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dolby Laboratories, Inc.
CENTRAL INDEX KEY: 0001308547
STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794]
IRS NUMBER: 900199783
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0927
BUSINESS ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415 558 0200
MAIL ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-02
0
0001308547
Dolby Laboratories, Inc.
DLB
0001214091
TEVANIAN AVADIS
C/O DOLBY LABORATORIES, INC.
1275 MARKET STREET
SAN FRANCISCO
CA
94103
1
0
0
0
Class A Common Stock
2021-02-02
4
A
0
2661
0.00
A
2661
D
Class A Common Stock
2021-02-02
4
S
0
1814
90.00
D
50561
I
By Avadis Tevanian Jr. and Nancy Tevanian Trust u/a/d May 29 1996
Award represents a total of 2,661 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2022 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date.
Shares held following the reported transactions include 2,661 restricted stock units, which are subject to forfeiture until they vest.
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.
/s/ Daniel Rodriguez, as Attorney-in-Fact for Avadis Tevanian
2021-02-04